Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?

Chan Y. Cheah; John F. Seymour

doi:10.3109/10428194.2013.830306

Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?

Chan Y. Cheah
, John F. Seymour

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	471-473
Number of pages	3
Journal	LEUKEMIA & LYMPHOMA
Volume	55
Issue number	3
DOIs	https://doi.org/10.3109/10428194.2013.830306
Publication status	Published - Mar 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3109/10428194.2013.830306

Cite this

@article{1d1f85eec2764b579599312a16465c99,

title = "Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?",

author = "Cheah, \{Chan Y.\} and Seymour, \{John F.\}",

year = "2014",

month = mar,

doi = "10.3109/10428194.2013.830306",

language = "English",

volume = "55",

pages = "471--473",

journal = "LEUKEMIA \& LYMPHOMA",

issn = "1042-8194",